Oil Pulling Whitening Mouthwash
18 juin 2026 mis à jour par: Bennett Amaechi, The University of Texas Health Science Center at San Antonio
Evaluation of Tooth Whitening Efficacy of GuruNanda Oil Pulling Oral Rinse.
The goal of this study is to evaluate the tooth whitening efficacy of Oil Pulling oral rinse compared to a competitor's whitening mouthwash and a water-based mouthwash (placebo).
Each participant will use one of three mouthwashes: GuruNanda Oil Pulling oral rinse (test), Competitor's mouthwash (positive), Water-based oral rinse (placebo).
All mouthwashes will be used once daily last thing before bed at night.
Data will be collected on tooth shade evaluated on the anterior teeth.
Aperçu de l'étude
Statut
Recrutement
Les conditions
Description détaillée
A total of 120 subjects who met all necessary requirements for selection as subjects will be stratified into three balanced groups (40 per group) according to age, gender, and their mean baseline tooth shade measured using the VITA Easy Shade Advance Spectrophotometer.
Males and females aged between 18 and 60 years will be enrolled.
The three groups will be randomly assigned to use one of three test mouthwashes: GuruNanda Oil Pulling oral rinse (test), Competitor's mouthwash (positive), Water-based oral rinse (placebo).
Subjects will be instructed to use their assigned mouthwash as an adjunct oral hygiene product for the 8-week treatment duration.
All subjects will be provided with the same brand of toothpaste (non-antimicrobial) and a soft-bristled toothbrush to use for their routine daily toothbrushing for the 8-week treatment duration.
All study products will be used according to their manufacturers' instructions.
However, to facilitate double blinding, only the Randomizer will dispense the products, give instructions on the use of the products, and supervise the first use of the product at the clinical facility.
The clinical Examiner and other study team members will not discuss product-use with the subjects.
All mouthwash will be used once daily before bed at night, while toothbrushing will be performed twice daily in the morning and before bed at night.
For each test subject, assessment data will be collected at baseline, 4 weeks, and 8 weeks.
Data will be collected on tooth shade evaluated using the Lobene Stain Index, VITA Bleachedguide 3D-Master shade guide and the Vita EasyShade® Advance 4.0 Spectrophotometer on the anterior teeth.
The average summary scores will be calculated for each group on each of these measurements.
All dental examinations for data collection in all 120 subjects will be conducted by the same Clinical Examiner throughout the study.
Subjects will be examined and queried on adverse events at each study visit.
Type d'étude
Interventionnel
Inscription (Estimé)
120
Phase
- N'est pas applicable
Contacts et emplacements
Cette section fournit les coordonnées de ceux qui mènent l'étude et des informations sur le lieu où cette étude est menée.
Coordonnées de l'étude
- Nom: Bennett T Amaechi, BDS, MS, PhD, MFDS RCPS, FADI
- Numéro de téléphone: 210-567-3185
- E-mail: amaechi@uthscsa.edu
Sauvegarde des contacts de l'étude
- Nom: Razina Vohra
- Numéro de téléphone: 210-643-9803
- E-mail: vohrar@uthscsa.edu
Lieux d'étude
-
-
Texas
-
San Antonio, Texas, États-Unis, 78229
- Recrutement
- Clinical Research Facility of the Center for Oral Health and Research, UTHSA
-
Contact:
- Bennett T Amaechi, BDS, MS, PhD, MFDS RCPS, FADI
- Numéro de téléphone: 210-567-3185
- E-mail: amaechi@uthscsa.edu
-
Contact:
- Razina Vohra
- Numéro de téléphone: 210-643-9803
- E-mail: vohrar@uthscsa.edu
-
-
Critères de participation
Les chercheurs recherchent des personnes qui correspondent à une certaine description, appelée critères d'éligibilité. Certains exemples de ces critères sont l'état de santé général d'une personne ou des traitements antérieurs.
Critère d'éligibilité
Âges éligibles pour étudier
- Adulte
Accepte les volontaires sains
Non
La description
Inclusion Criteria:
- Adult subjects aged 18-60, that are in good health.
- Subject must have at least 2 natural anterior teeth, each having a mean Lobene composite score of ≥ 1.5 on the facial surfaces as assessed by the Investigator.
- Subject's front teeth shade should be 9 or darker (meaning shade score should be between 9 and 29), as assessed by the Vita bleachguide 3D-Master and the Vita EasyShade device.
- Subjects should understand the information provided about the investigative nature of the treatment, possible benefits and side effects. Subjects will sign the Informed Consent Form.
- The subjects should be willing to comply with the study procedure and schedule, including the follow up visits, and will refrain from using any other teeth whitening technologies during this period.
- The subject did not perform any procedure for teeth whitening (either at home or in clinic) at least 3 years prior to participating in the study.
Exclusion Criteria:
- Pregnant or nursing by subject report.
- Known allergic reaction to any of the study mouthwashes or any of their components. Participant has completed the screening questionnaire (Exclusion due to Known Allergens).
- Any active condition in the oral cavity at the discretion of the investigator.
- Any surgery or dental procedure in the treated area within 3 months prior to treatment, or before complete healing.
- Subjects that do not brush regularly.
- Any condition that might make it unsafe for the subject to participate in the study, at the discretion of the investigator.
- Heavy tobacco use, including cigarettes, cigars, or smokeless tobacco.
- Consumption of stain-causing substances (e.g., red wine, coffee, tea) that cannot be avoided during the study period.
- Use of medications that may affect tooth discoloration (e.g., tetracyclines, chlorhexidine).
- Participation in another clinical trial within the last 30 days.
- Presence of orthodontic appliances, except for removable retainers.
- Signs of advanced enamel wear, dentin exposure, or tooth fractures.
Plan d'étude
Cette section fournit des détails sur le plan d'étude, y compris la façon dont l'étude est conçue et ce que l'étude mesure.
Comment l'étude est-elle conçue ?
Détails de conception
- Objectif principal: Autre
- Répartition: Randomisé
- Modèle interventionnel: Affectation parallèle
- Masquage: Double
Armes et Interventions
Groupe de participants / Bras |
Intervention / Traitement |
|---|---|
|
Comparateur actif: Contrôle positif
|
positive control
|
|
Comparateur placebo: Contrôle négatif
|
negative control
|
|
Expérimental: Tester le produit
|
Test product
|
Que mesure l'étude ?
Principaux critères de jugement
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Measurement by the VITA Easyshade Advance 4.0
Délai: Baseline to 8 weeks
|
A probe tip is placed on an area of the enamel surface that has underlying dentin and a measurement made of the shade
|
Baseline to 8 weeks
|
|
VITA Bleachguide 3-D Master Shade Guide
Délai: Baseline to 8 weeks
|
A single examiner will perform visual tooth shade assessment under standard lighting conditions.
Tooth shade will be scored on selected anterior teeth .
The tab marking system includes interpolated shade guide units (sgu) ranging from 1 to 29 sgu with a lower score indicating more whitening.
Subject shade rank scores will be determined for each visit by calculating the mean value across the selected anterior teeth scored.
|
Baseline to 8 weeks
|
|
Lobene Stain Index
Délai: Baseline to 8 weeks
|
Measure of intensity and extent of extrinsic stain on the facial surfaces of 12 anterior teeth.
The teeth are divided into regions which are scored separately.
Intensity is scored from 0 (no stain) to 3 (heavy stain; dark brown to black) and extent is scored from 0 (no stain) to 3 (stain covering over two-thirds of the region).
Scores will be averaged for each subject for intensity (sum of all intensity scores/all sites graded) and extent (sum of all extent scores/all sites graded), and the composite stain score calculated by multiplying the mean stain intensity by the mean stain extent.
|
Baseline to 8 weeks
|
Mesures de résultats secondaires
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Satisfaction: Subjective participant questionnaires
Délai: 8 weeks
|
Front teeth appearance: Five subjects will be selected from each study group for this purpose.
A digital imaging system, camera (Canon EOS 50D), will be used.
The camera (Canon EOS 50D) is to be attached to a standardized head positioner to allow for consistency between images.
A digital exposure will be made with include lips/cheeks retracted and anterior teeth aligned edge to edge.
Another digital exposure will also be made with the subjects smiling but covering just the area between nose and chin.
Photographs will be taken as digital images before the treatment and at the final study visit when efficacy assessments are completed.
Lighting conditions will be as described for the tooth shade assessments to ensure uniformity among subjects and consistency across time.
|
8 weeks
|
|
Satisfaction Questionnaire
Délai: 8 weeks
|
A questionnaire containing 6 scorable items with a potential score of (a) 5=Very High to (e)1=Very Low and 4 free response questions.
Total scores range from 6-30 with a higher score indicating greater satisfaction
|
8 weeks
|
Collaborateurs et enquêteurs
C'est ici que vous trouverez les personnes et les organisations impliquées dans cette étude.
Collaborateurs
Dates d'enregistrement des études
Ces dates suivent la progression des dossiers d'étude et des soumissions de résultats sommaires à ClinicalTrials.gov. Les dossiers d'étude et les résultats rapportés sont examinés par la Bibliothèque nationale de médecine (NLM) pour s'assurer qu'ils répondent à des normes de contrôle de qualité spécifiques avant d'être publiés sur le site Web public.
Dates principales de l'étude
Début de l'étude (Réel)
1 mai 2026
Achèvement primaire (Estimé)
31 août 2026
Achèvement de l'étude (Estimé)
31 août 2026
Dates d'inscription aux études
Première soumission
18 juin 2026
Première soumission répondant aux critères de contrôle qualité
18 juin 2026
Première publication (Réel)
24 juin 2026
Mises à jour des dossiers d'étude
Dernière mise à jour publiée (Réel)
24 juin 2026
Dernière mise à jour soumise répondant aux critères de contrôle qualité
18 juin 2026
Dernière vérification
1 juin 2026
Plus d'information
Termes liés à cette étude
Mots clés
Termes MeSH pertinents supplémentaires
Autres numéros d'identification d'étude
- STUDY00001211
Plan pour les données individuelles des participants (IPD)
Prévoyez-vous de partager les données individuelles des participants (DPI) ?
NON
Informations sur les médicaments et les dispositifs, documents d'étude
Étudie un produit pharmaceutique réglementé par la FDA américaine
Non
Étudie un produit d'appareil réglementé par la FDA américaine
Non
Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .